Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies
TL Wexler, G Page‐Wilson - British Journal of Clinical …, 2023 - Wiley Online Library
Dopamine agonists are a key tool in the therapeutic arsenal of endocrinologists worldwide.
They exert their effects by binding to dopamine‐2 (D2) receptors expressed by pituitary …
They exert their effects by binding to dopamine‐2 (D2) receptors expressed by pituitary …
[HTML][HTML] Central hyperthyroidism combined with Graves' disease: case series and review of the literature
C Mo, H Chen, Q Zhang, Y Guo… - European thyroid …, 2023 - etj.bioscientifica.com
Background Central hyperthyroidism is characterized by elevated free thyroid hormone and
unsuppressed thyroid-stimulating hormone (TSH), and this laboratory feature includes TSH …
unsuppressed thyroid-stimulating hormone (TSH), and this laboratory feature includes TSH …
Thyrotropin-secreting tumor “TSH-PitNET”: From diagnosis to treatment
C Briet, V Suteau, F Illouz, P Rodien - Annales d'Endocrinologie, 2023 - Elsevier
Thyrotropic adenomas (TSH-PitNET) are the rarest pituitary tumours. Most TSH-PitNETs are
secreting adenoma, with a biological picture of inappropriate TSH secretion (moderately …
secreting adenoma, with a biological picture of inappropriate TSH secretion (moderately …
Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)‐secreting pituitary adenomas
J Liu, Y Yang, L Duan, X Chai, H Zhu… - Clinical …, 2023 - Wiley Online Library
Context Somatostatin analogs are recommended for preoperative therapy in thyrotrophin
secreting pituitary adenomas (TSHomas). Octreotide suppression test (OST) was designed …
secreting pituitary adenomas (TSHomas). Octreotide suppression test (OST) was designed …
[HTML][HTML] The effect of preoperative short-term octreotide treatment to surgery in thyrotropin-secreting pituitary adenomas: a retrospective cohort study
R Zhao, K Fan, W Wan - BMC Endocrine Disorders, 2023 - Springer
Background To prevent thyroid storm and ensure surgical safety, it is imperative to regulate
excessive thyroid hormone levels in patients with thyrotropin-secreting pituitary adenomas …
excessive thyroid hormone levels in patients with thyrotropin-secreting pituitary adenomas …
The molecular biology of thyrotroph pituitary neuroendocrine tumors
K Horiguchi - Endocrine Journal, 2023 - jstage.jst.go.jp
Pituitary neuroendocrine tumors (PitNETs), which were formerly known as pituitary
adenomas, are classified in 5th Edition of the WHO Classification of Endocrine and …
adenomas, are classified in 5th Edition of the WHO Classification of Endocrine and …